Clinical Trial Update: Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure [Phase 3]

View source ↗

Summary

Phase 3 trial comparing parecoxib, celecoxib, and oxycodone for pain control after transcatheter chemoembolization in liver cancer patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer
• Postoperative Pain

Drugs mentioned

• Celecoxib (Celecoxib)
• Oxycodone (oxycodone)
• Parecoxib (parecoxib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Liver Cancer, Pain Postoperative | Phase 3 | Status: COMPLETED